Company: MDCXW
Filing Date: 2025-05-05
Form Type: 253G2
Source: 0001062993-25-008440
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-05
Form: 253G2
Chunk 4
---
 and 308 of Regulation S-K under the Exchange Act, paragraphs 4 and 5 of the Section 302 certifications have been omitted. As a result, Item 15 of Part IV has been amended to reflect the filing and furnishing of these new certifications.

Except as otherwise expressly noted herein, this Amendment No. 1 does not modify or update in any way the financial position, results of operations, cash flows, or other information contained or incorporated in, including the exhibits thereto, the Original Form 10-K, nor does it reflect events occurring after the filing of the Original Form 10-K. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Form 10-K and with our other filings made with the SEC subsequent to the filing of the Original Annual Report.

In this Amendment No. 1, we provide our website address, www.medicuspharma.com, to disclose that certain information is available on our website. Information contained on, or that can be accessed through, our website is not incorporated by reference into this Amendment No. 1, and references to our website address in this Amendment No. 1 are inactive textual references only.

<div align='center'>TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-K/A (Amendment No.1)
For the Fiscal Year Ended December 31, 2024</div>

| PART III                                                                                                 |  1 |
| Item 10. Directors, Executive Officers and Corporate Governance.                                         |  1 |
| Item 11. Executive Compensation.                                                                         | 10 |
| Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. | 18 |
| Item 13. Certain Relationships and Related Transactions, and Director Independence.                      | 28 |
| Item 14. Principal Accountant Fees and Services.                                                         | 29 |
| PART IV                                                                                                  | 31 |
| Item 15. Exhibits, Financial Statement Schedules                                                         | 31 |
| Item 16. Form 10-K Summary.                                                                              | 31 |

<div align='center'>PART III</div>

Item 10. Directors, Executive Officers and Corporate Governance.

Information Regarding Directors

Set forth below is certain information with respect to our current directors as of April 15, 2025.

| Name and                         
 Location of                      
 Residence                        |     | Age |     | Position(s) |     | Principal Occupation During the                                                    
 Past Five Years (6)                                                                |